Optipharm.CO.LTD (153710) — Cash Flow Reinvestment Rate
Optipharm.CO.LTD (153710) has a Cash Flow Reinvestment Rate of 1.56x as of September 2025, reinvesting ₩493.26 Million (capex ₩97.26 Million plus investments ₩396.00 Million) from operating cash flow of ₩315.25 Million. Check 153710 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Optipharm.CO.LTD Cash Flow Reinvestment Rate (2016–2019)
Historical reinvestment intensity for Optipharm.CO.LTD across 4 annual periods. Explore Optipharm.CO.LTD (153710) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Optipharm.CO.LTD (2016–2019)
Year-by-year capital reinvestment analysis for Optipharm.CO.LTD. For live market cap and broader valuation context, see 153710 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 13.02x | ₩5.83 Billion | ₩447.47 Million | ₩626.46 Million | ▲ +6121.0% |
| 2018 | 0.21x | ₩251.91 Million | ₩1.20 Billion | ₩202.91 Million | ▼ -92.4% |
| 2017 | 2.77x | ₩722.33 Million | ₩260.86 Million | ₩670.33 Million | ▲ +473.4% |
| 2016 | 0.48x | ₩415.95 Million | ₩861.36 Million | ₩391.95 Million | — |